Companion Animal Vaccines Market By Product Type (Canine Vaccines, Feline Vaccines, Avian Vaccines, and Equine Vaccines), By Disease Type (Canine Distemper, Canine Parvovirus, Feline Rabies and Others), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines, and Subunit Vaccines), By Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce) and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Companion Animal Vaccines Market was valued at USD 3.3 billion in 2023 and is poised to grow at a CAGR of 6.6% from 2024-2030. Companion animals such as dogs, cats, and horses are becoming more common in cities. The growing prevalence of various animal diseases, technological advancements in diagnostic and therapeutic with efficient drugs, developments in the field of biotechnology, and growing consumer awareness as a result of social media government initiatives are all driving demand in the global market for companion animal vaccines. Various countries have enacted strict regulations to conserve and safeguard companion animals, which must be accompanied by regular animal health checks. Another aspect that is positively impacting the global companion animal vaccines market is this. However, growing vaccine storage costs and insufficient reporting methods are preventing the global companion animal vaccines business from reaching its full potential. Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the caregivers and pet owners to adopt better healthcare services to the companion animals this is projected to drive market revenue growth over the forecast period.

Global Companion Animal Vaccines Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Companion Animal Vaccines Market Dynamics

There has been a rise in awareness regarding pet health among pet owners across the developed and developing economies expected to drive market revenue growth over the forecast period. Moreover, several studies on human and companion animal interactions showed that association with companion animals results in positive health benefits. Therefore, it is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are the primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal vaccines over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Companion Animal Vaccines Market Segmentation

By Product Type
  • Canine Vaccines
  • Feline Vaccines
  • Avian Vaccines
  • Equine Vaccines
By Disease Type
  • Canine Distemper
  • Canine Parvovirus
  • Feline Rabies
  • Others
By Vaccine Type
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant vaccines
  • Toxoid vaccines
  • Conjugate Vaccines
  • DNA Vaccines
  • Subunit Vaccines
By Distribution Channel
  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Veterinary Clinics
  • E-Commerce

Frequently Asked Questions

The companion animal vaccines market size was valued at USD 3.3 billion in 2023

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

Bayer AG (Germany) Boehringer Ingelheim GmbH (Germany) Ceva Santé Animale (France) Eli Lilly and Company (U.S) Heska Co. (U.S) Hester biosciences (India)

1.Executive Summary
2.Global Companion Animal Vaccines Market Introduction 
2.1.Global Companion Animal Vaccines Market  - Taxonomy
2.2.Global Companion Animal Vaccines Market  - Definitions
2.2.1.Product Type 
2.2.2.Disease Type
2.2.3.Vaccine Type
2.2.4.Distribution Channel
2.2.5.Region
3.Global Companion Animal Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Companion Animal Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Companion Animal Vaccines Market  By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Canine Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Feline Vaccines
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Avian Vaccines
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Equine Vaccines
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Companion Animal Vaccines Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Canine Distemper
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Canine Parvovirus
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Feline Rabies
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Companion Animal Vaccines Market  By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Live Attenuated Vaccines
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Inactivated Vaccines
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Recombinant vaccines
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Toxoid vaccines
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Conjugate Vaccines
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. DNA Vaccines
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Subunit Vaccines
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8.Global Companion Animal Vaccines Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Veterinary Pharmacies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Veterinary Hospitals
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Veterinary Clinics
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. E-Commerce
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Companion Animal Vaccines Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Canine Vaccines
10.1.2.Feline Vaccines
10.1.3.Avian Vaccines
10.1.4.Equine Vaccines
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Canine Distemper
10.2.2.Canine Parvovirus
10.2.3.Feline Rabies
10.2.4.Others
10.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Live Attenuated Vaccines
10.3.2.Inactivated Vaccines
10.3.3.Recombinant vaccines
10.3.4.Toxoid vaccines
10.3.5.Conjugate Vaccines
10.3.6.DNA Vaccines
10.3.7.Subunit Vaccines
10.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Veterinary Pharmacies
10.4.2.Veterinary Hospitals
10.4.3.Veterinary Clinics
10.4.4.E-Commerce
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Canine Vaccines
11.1.2.Feline Vaccines
11.1.3.Avian Vaccines
11.1.4.Equine Vaccines
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Canine Distemper
11.2.2.Canine Parvovirus
11.2.3.Feline Rabies
11.2.4.Others
11.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Live Attenuated Vaccines
11.3.2.Inactivated Vaccines
11.3.3.Recombinant vaccines
11.3.4.Toxoid vaccines
11.3.5.Conjugate Vaccines
11.3.6.DNA Vaccines
11.3.7.Subunit Vaccines
11.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Veterinary Pharmacies
11.4.2.Veterinary Hospitals
11.4.3.Veterinary Clinics
11.4.4.E-Commerce
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Canine Vaccines
12.1.2.Feline Vaccines
12.1.3.Avian Vaccines
12.1.4.Equine Vaccines
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Canine Distemper
12.2.2.Canine Parvovirus
12.2.3.Feline Rabies
12.2.4.Others
12.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Live Attenuated Vaccines
12.3.2.Inactivated Vaccines
12.3.3.Recombinant vaccines
12.3.4.Toxoid vaccines
12.3.5.Conjugate Vaccines
12.3.6.DNA Vaccines
12.3.7.Subunit Vaccines
12.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Veterinary Pharmacies
12.4.2.Veterinary Hospitals
12.4.3.Veterinary Clinics
12.4.4.E-Commerce
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Canine Vaccines
13.1.2.Feline Vaccines
13.1.3.Avian Vaccines
13.1.4.Equine Vaccines
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Canine Distemper
13.2.2.Canine Parvovirus
13.2.3.Feline Rabies
13.2.4.Others
13.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Live Attenuated Vaccines
13.3.2.Inactivated Vaccines
13.3.3.Recombinant vaccines
13.3.4.Toxoid vaccines
13.3.5.Conjugate Vaccines
13.3.6.DNA Vaccines
13.3.7.Subunit Vaccines
13.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Veterinary Pharmacies
13.4.2.Veterinary Hospitals
13.4.3.Veterinary Clinics
13.4.4.E-Commerce
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Companion Animal Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Canine Vaccines
14.1.2.Feline Vaccines
14.1.3.Avian Vaccines
14.1.4.Equine Vaccines
14.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Canine Distemper
14.2.2.Canine Parvovirus
14.2.3.Feline Rabies
14.2.4.Others
14.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Live Attenuated Vaccines
14.3.2.Inactivated Vaccines
14.3.3.Recombinant vaccines
14.3.4.Toxoid vaccines
14.3.5.Conjugate Vaccines
14.3.6.DNA Vaccines
14.3.7.Subunit Vaccines
14.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Veterinary Pharmacies
14.4.2.Veterinary Hospitals
14.4.3.Veterinary Clinics
14.4.4.E-Commerce
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Bayer AG (Germany)
15.2.2.Boehringer Ingelheim GmbH (Germany)
15.2.3.Ceva Santé Animale (France)
15.2.4.Eli Lilly and Company (U.S)
15.2.5.Heska Co. (U.S)
15.2.6.Hester biosciences (India)
15.2.7.Merck & Co., Inc. (U.S)
15.2.8.Vétoquinol S.A. (France)
15.2.9.Virbac S.A. (France)
15.2.10.Zoetis Inc. (U.S)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Heska Co. (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Adjacent Markets